Dr. Friedmann is a primary care internist, addiction medicine clinician and established addiction health services researcher whose research examines the organization of addiction treatment services across the substance abuse treatment, medical and criminal justice systems.
Dr. Friedmann is Professor of Medicine and Health Services, Policy and Practice at the Warren Alpert Medical School and School of Public Health at Brown University and directs the Research Section in the Division of General Internal Medicine at Rhode Island Hospital and the Center of Innovation in Long-Term Services and Support for Veterans with Vulnerabilities at the Providence VA Medical Center. Dr. Friedmann has been PI of the Rhode Island Research Center of NIDA’s Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) since 2004. He currently chairs the workgroup for CJ-DATS’ 18-site, cluster-randomized implementation study “Medication Assisted Treatment in Community Correctional Environments (MATICCE).” He is also site PI for a five-site trial of depot naltrexone for opioid-dependent ex-offenders. He was previously lead investigator of Step’n Out, a six-site, randomized trial of integrated community supervision and outpatient addiction treatment for drug-dependent parolees. He is a Fellow of the ASAM and American College of Physicians, a past president of the Association for Medical Education and Research in Substance Abuse (AMERSA), and Associate Editor of the Journal of Substance Abuse Treatment. Dr. Friedmann was recently elected to the American Board of Addiction Medicine.